Special Situations Review
Transcription
Special Situations Review
FEBRUARY 2001 Special Situations Review TONY YUE, PH.D. [email protected] / (604) 643-7542 HIGHLIGHTS • • • The Top January Winners: Ø Versacold (ICE : TSE : $6.00) up 26.3% Ø Spar Aerospace (SPZ : TSE : $10.20) up 23.6% Ø Aastra Technologies (AAH : TSE : $10.75) up 23.6% Ø Strongco (SQP : TSE : $1.72) up 22.9% Ø MDS Inc. (MDS : TSE : $26.70) up 20.3% Ø CAE Inc. (CAE : TSE : $20.70) down 15.2% Ø Toromont Industries (TIH : TSE : $15.30) down 12.6% Ø The Boyd Group (BYD.A : TSE : $1.80) down 10.0% Ø COM DEV International (CDV : TSE : $14.00) down 9.7% Ø Aastra Technologies (AAH : TSE : $10.75) up 23.6% Ø CRS Robotics (ROB : TSE : $2.85) up 6.0% Ø Finning International (FTT : TSE : $12.10) down 4.7% Ø Gennum Corp. (GND : TSE : $14.00) up 6.9% Ø MDS Inc. (MDS : TSE : $26.70) up 20.3% Ø Patheon (PTI : TSE : $13.80) down 7.1% Ø Spar Aerospace (SPZ : TSE : $10.20) up 23.6% The Bottom January Losers: Year-to-date Performance of Our 2001 Top Picks: JANUARY 31, 2001 2001-040 MEMBER OF ALL CANADIAN STOCK EXCHANGES AND THE INVESTMENT DEALERS ASSOCIATION OF CANADA VANCOUVER TORONTO CALGARY MONTREAL LONDON PARIS SPECIAL SITUATIONS TABLE OF CONTENTS Aastra Technologies Limited (AAH : TSE) ................................................................................................3 Boyd Group Inc., The (BYD.A : TSE) ........................................................................................................3 Buhler Industries Inc. (BUI : TSE) ..............................................................................................................4 CAE Inc. (CAE : TSE).................................................................................................................................4 Canadian Medical Laboratories Limited (CLC : TSE)................................................................................5 COM DEV International (CDV : TSE) .......................................................................................................5 CRS Robotics Corporation (ROB : TSE) ....................................................................................................6 Finning International (FTT : TSE)...............................................................................................................6 Gennum Corporation (GND : TSE).............................................................................................................7 MDS Inc. (MDS : TSE) ...............................................................................................................................7 Patheon Inc. (PTI : TSE)..............................................................................................................................8 Spar Aerospace Limited (SPZ : TSE)..........................................................................................................8 Strongco Inc. (SQP : TSE)...........................................................................................................................9 Toromont Industries Ltd. (TIH : TSE).........................................................................................................9 Versacold Corporation (ICE : TSE)...........................................................................................................10 Wajax Limited (WJX : TSE) .....................................................................................................................10 JANUARY 31, 2001 2 SPECIAL SITUATIONS Aastra Technologies (AAH : TSE : $10.75) Recommendation: STRONG BUY 12-month target price: $20.00 52-week price range: $17.00–5.00 Shares O/S: basic 14.2M fully diluted 14.7M Float: 76% Indicated dividend: Nil Weekly trading volume: 79,000 Market capitalization: $152.7M Y/E Dec 31 Sales EBITDA EPS 1998A $37.2M $2.3M $0.16 1999A $97.1M $9.0M $0.55 2000E $190.0M $27.5M $1.25 2001F $220.0M $33.6M $1.40 Sector: Website: • • P/E 67.2X 19.5X 8.6X 7.7X Technology-Hardware www.aastra.com Although Aastra shares rebounded 23.6% in January market valuation of the company remains low given its growth record, promising outlook and a strong, debt free balance sheet. Management faced considerable challenges in f2000 but has met all these challenges well. We are convinced that Aastra can continue to grow profitably. It appears that investors remain skeptical on the growth prospects of the company. The company’s technology focus for growth includes continued enhancement of existing terminals and network products, introduction and development of web-enabled appliance, enterprise voice over IP and enterprise wireless products. Aastra is among our TOP PICKS for 2001. The Boyd Group (BYD.A : TSE $1.80) Recommendation: STRONG BUY 12-month target price: $4.50 52-week price range: $3.15–1.45 Shares O/S: basic 12.9M fully diluted 18.0M Float: 53% Indicated dividend: Nil Weekly trading volume: 5,000 Market capitalization: $23.2M Y/E Dec 31 Sales EBITDA EPS 1998A $28.7M $2.8M $0.050 1999A $54.6M $5.9M $0.095 2000E $95.0M $10.4M $0.170 2001F $150.0M $17.0M $0.230 Sector: Website: P/E 36.0X 18.9X 10.6X 7.8X Wholesale Distributors www.boydgroup.com • Boyd shares continued to drift in spite of the company’s growth record and financial performance. It seems that investors have little interest in an acquisition driven growth, consolidation story. While the collision repair business may appear to be unexciting, GM has recently launched Goodwrench auto body centers with the objective to establish a national recognized collision repair network. Caliber collision centers also added over 20 stores in 2000. These activities suggest the appeal and profit potential of being a large player in the industry. Note that Boyd also acquired 12 collision repair locations in US during 2000. • We expect Boyd will continue to be a leading consolidator in the highly fragmented, $40 billion collision repair industry in North America. While BYD.A shares offer attractive value, investors will need patience. JANUARY 31, 2001 3 SPECIAL SITUATIONS Buhler Industries (BUI : TSE : $3.35) Recommendation: BUY 12-month target price: $3.75 52-week price range: $3.74-2.65 Shares O/S: basic 24.2M fully diluted 24.7M Float: 35% Indicated dividend: $0.10 Weekly trading volume: 6,000 Market capitalization: $81.1M Y/E Sep 30 Revenue EBITDA EPS 1998A $89.2M $16.9M $0.29 1999A $80.0M $14.4M $0.24 2000E $116.7M $15.9M $0.30 2001F $200.0M $20.0M $0.32 Sector: Website: P/E 11.6X 14.0X 11.2X 10.5X Fabricating & Engineering www.buhler.com • Reported exceptionally strong results for Q1/f01: EPS were up 120% to $0.11 and revenue increased 3.2-fold to $59.2 million. Sales of Buhler Versatile tractors accounted for about 90% of the revenue growth, and unusually low overhead vis-à-vis the higher revenue contributed to the income growth. The ongoing strike at the newly acquired Versatile tractor plant will impact performance of future quarters. • Meanwhile, Buhler continues to build and expand its dealer network, to develop new products, and to position itself for an eventual recovery in the farm economy. Buhler shares remain a BUY for patient investors. CAE Inc. (CAE : TSE $20.70) Recommendation: MARKET PERFORM 12-month target price: $24.00 52-week price range: $25.30–10.25 Shares O/S: basic 107.7M fully diluted 110.4M Float: 100% Indicated dividend: $0.20 Weekly trading volume: 898,000 Market capitalization: $2.23B Y/E Mar 31 Revenue EBIT EPS P/E 1999A $905.9M $113.9M $0.66 31.4X 2000A $1,164.3M $141.5M $0.83 24.9X 2001E $1,195.0M $195.0M $1.12 18.5X 2002F $1,265.0M $218.0M $1.35 15.3X Sector: Website: Technology-Hardware www.cae.com • CAE recently announced the rationalization of its sawmill machinery operations in response to depressed market conditions (lumber prices are at a five-year low) in the forest products industry. About 160 positions or 20% of the work force of the Wood Products group, primary associated with the operations in Salmon Arm, British Columbia and Portland, Oregon will be affected. However, the Pulp and Paper division will remain intact. Note that Forestry Systems accounted for 28% or $163.4 million of f2001 first half revenue ($581.3 million) and also 28% or $27.6 million of the EBIT operating income ($100.2 million). • Nevertheless, management stated that CAE’s outlook for f2001 and the commitment to double net earnings within a three-year time frame remain unchanged. The future for commercial simulation and training is positive and the entry into the $13 billion global pilot training market should pay off. JANUARY 31, 2001 4 SPECIAL SITUATIONS Canadian Medical Laboratories (CLC : TSE : $19.00) Recommendation: BUY 12-month target price: $20.00 (under review) 52-week price range: $23.00–13.00 Shares O/S: basic 20.4M fully diluted 21.3M Float: 54% Indicated dividend: Nil Weekly trading volume: 656,500 Market capitalization: $387.6M Y/E Sep 30 Revenue EBITDA EPS P/E 1998A $74.5M $26.4M $0.68 27.9X 1999A $130.4M $55.4M $1.21 15.7X 2000E $186.0M $77.5M $1.65 11.5X 2001F $206.0M $86.0M $1.80 10.6X Sector: Website: • • Biotech/Pharmaceuticals www.canmedlab.com Canadian Medical Laboratories shares recovered well after it announced in late 2000 the entry into the drug development arena through a new subsidiary Cipher Pharmaceuticals Limited. Cipher has since completed three licensing agreements with Galephar Pharmaceutical for the development of a novel lipid-lowering drug, a new sustained release Tramadol for chromic pain syndromes treatment, and a new formulation of Isotretinoin for severe nodular acne treatment. The company plans to capitalize its drug development costs. Meanwhile, the company will continue to expand its SMO business that organizes and manages multi-site clinical investigations on behalf of CROs. Patient investors could realize significant returns in two to three years. COM DEV International (CDV : TSE : $14.00) Recommendation: 12-month target price: 52-week price range: Shares O/S: basic fully diluted Float: Indicated dividend: Weekly trading volume: Market capitalization: Y/E Oct 31 1998A 1999A 2000E 2001F Revenue $172.1M $162.4M $205.5M $300.0M Sector: Website: SPECULATIVE BUY $20.00 $22.20-5.00 43.1M 47.8M 78% Nil 441,000 $610.4M EBITDA $6.5M $(6.9)M $12.5M $21.0M EPS $(0.57) $(2.12) $(0.11) $0.15 P/E n.a. n.a. n.a. 93.3X Technology-Hardware www.comdev.ca • COM DEV shares pulled back 10% in January after gaining 230% in 2000. We think COM DEV shares will stay in a narrow trading range until progress is evidenced on M/ERGY, the new high-speed wireless Internet data system. We believe that investors are now more cautious as an increased number of wireless equipment suppliers have indicated a slower growth period ahead. • Although strong order input for both space and wireless products should fuel f2001 revenue growth to the $300 million level, net earnings growth will be affected by high production costs in China and significant R&D investment (about $30 million) for M/ERGY. While successful commercialization of M/ERGY will provide significant return and will transform COM DEV into a system company from a component supplier, the risk is also high. We rate COM DEV shares as a SPECULATIVE BUY for aggressive investors. JANUARY 31, 2001 5 SPECIAL SITUATIONS CRS Robotics (ROB : TSE : $2.85) Recommendation: STRONG BUY 12-month target price: $6.00 52-week price range: $5.00–2.00 Shares O/S: basic 9.7M fully diluted 10.5M Float: 67% Indicated dividend: Nil Weekly trading volume: 48,600 Market capitalization: $27.6M Y/E Dec 31 Sales EBITDA EPS 1998A $13.5M $1.1M $0.09 1999A $13.9M $1.5M $0.12 2000E $18.3M $1.6M $0.11 2001F $29.0M $2.8M $0.18 Sector: Website: P/E 31.7X 23.8X 25.9X 15.8X Biotechnology/Pharmaceuticals www.crsrobotics.com • While earnings growth in the first nine months of f2000 was affected by the company’s decision to invest heavily in sales/marketing to grow sales, this strategy should pay off beginning in f2001, and perhaps as early as in Q4/f00. Our EPS (before amortization of goodwill associated with the Robocon acquisition) and sales forecast for f2000 and f2001 could be on the conservative side. There is room for upside surprise. • The purchase of Robocon will add over $6 million of profitable sales, and it will increase the global presence of CRS in lab automation. CRS has also expanded its product offerings to include diagnostic kits and consumables. CRS recently announced an OEM agreement with Robbins Scientific, the release of enhanced POLARA 1.3 software for the drug discovery and clinical trial markets, and a supply agreement with MDS Proteomics for automated protein expression platforms. CRS is one of our TOP PICKS for 2001. Finning International (FTT : TSE : $12.10) Recommendation: STRONG BUY 12-month target price: $17.00 52-week price range: $13.85–9.85 Shares O/S: basic 76.3M fully diluted 82.2M Float: 100% Indicated dividend: $0.20 Weekly trading volume: 641,000 Market capitalization: $923.2M Y/E Dec 31 Revenue CFPS EPS P/E 1998A $2,585M $2.89 $0.04 302.5X 1999A $2,230M $3.15 $0.75 16.1X 2000E $2,450M $3.40 $1.00 12.1X 2001F $3,000M $5.00 $1.25 9.7X Sector: Website: Merchandising-Wholesale Distributor www.finning.com • After an 18% gain in December 2000 to the $12.70 level, Finning shares have stayed in a narrow trading range so far in 2001. During January, Finning acquired Hewden Stuart Plc, the Mak business operation (a subsidiary of Caterpillar) in the UK and Ireland, as well as Sabre Perkins (also a subsidiary of Caterpillar). • The three acquisitions will add roughly C$615 million of profitable, annualized revenue, and will position Finning as a leader in the UK equipment rental market, and the world’s first Cat dealer supplying the entire range of marine engines manufactured by Caterpillar, from a single source in the UK. We are positive on the repositioning strategy of Finning and we have selected Finning shares as a TOP PICK for 2001. JANUARY 31, 2001 6 SPECIAL SITUATIONS Gennum (GND : TSE : $14.00) Recommendation: BUY 12-month target price: $20.00 52-week price range: $19.45–11.75 Shares O/S: basic 35.7M fully diluted 35.7M Float: 80% Indicated dividend: $0.12 Weekly trading volume: 50,000 Market capitalization: $499.8M Y/E Nov 30 Sales CFPS EPS 1999A $93.6M $0.62 $0.49 2000A $106.5M $0.72 $0.53 2001E $126.0M $0.80 $0.60 2002F $155.0M $1.00 $0.78 Sector: Website: P/E 28.6X 26.4X 23.3X 17.9X Technology-Hardware www.gennum.com • Although Gennum only posted a modest 8.2% increase in EPS for f2000 and management only expects stronger earnings growth to resume in the second half of f2001, we envision that the company will enter into another period of rapid growth beginning in f2002, similar to the growth period of f1994-f1998. High-speed datacom IC’s will be a key driver in the next phase of growth. • Gennum will begin to market new digital hearing products in f2001 and will also introduce its datacom IC’s. Meanwhile, sales of analog hearing products are holding up well, and demand for video products (for digital signal conversion and HDTV) also continues strong. Gennum is one of our TOP PICKS for 2001. MDS Inc. (MDS : TSE C$26.70 / MDZ : NYSE : US$17.75) Recommendation: BUY 12-month target price: C$28.00 (under review) 52-week price range: C$32.38–15.13 (TSE) Shares O/S: basic 139.5M fully diluted 145.8M Float: 80% Indicated dividend: C$0.08625 Weekly trading volume: 2.3M Market capitalization: C$3.7B Y/E Oct 31 Revenue EBITDA EPS P/E 1999A $1.19B $191.4M $0.70 38.1X 2000A $1.44B $203.3M $0.86 31.0X 2001E $1.67B $255.0M $0.73 36.6X 2002F $1.84B $299.0M $0.87 30.7X Sector: Website: • Biotechnology/Pharmaceuticals www.mdsintl.com MDS shares rebounded 20% in January. The confirmed commitment of an IPO for MDS Proteomics has removed considerable uncertainty. This subsidiary has made significant progress in building corporate infrastructure, including management team, capabilities, joint ventures and client base. Meanwhile, MDS Sciex has reached an agreement with Micralyne of Alberta to jointly develop microfluidic technology for use in drug discovery instrumentation. MDS itself has also acquired a majority interest in GenerationMD, a provider of web-based medical education for physicians, as part of the company’s e-health strategy. JANUARY 31, 2001 7 SPECIAL SITUATIONS • While the high expenditures planned for MDS Proteomics will impact f2001 results, we should see stronger earnings growth beginning in f2002. Progress at MDS Pharma Services will be an important factor. We like the risk/reward of investing in MDS and we have selected MDS shares as a TOP PICK for 2001. Patheon (PTI : TSE : $13.80) Recommendation: STRONG BUY 12-month target price: $17.00 52-week price range: $16.85–7.00 Shares O/S: basic 46.0M fully diluted 49.3M Float: 85% Indicated dividend: Nil Weekly trading volume: 223,000 Market capitalization: $641.7M Y/E Oct 31 Revenue EBITDA EPS 1999A $127.4M $20.0M $0.18 2000A $256.3M $34.2M $0.31 2001E $320.0M $45.0M $0.42 2002F $385.0M $60.0M $0.56 Sector: Website: • • P/E 76.7X 44.5X 32.9X 24.6X Biotechnology/Pharmaceuticals www.patheon.com Growth momentum continues very strong. EPS for f2000 increased 70% to $0.31 and revenues more than doubled to $256.3 million. While the BourgoinJallieu (France) and Swindon (UK) sites acquired from Aventise in Q1/f00 accounted for 83% of the revenue increase, North American operations also posted an organic growth of 23%. Year-end backlog rose to $65 million from $32.3 million. Management expects 20-25% internal growth for the North American operations in f2001, about 10% growth for the European operations, and some improvement in margins. Ongoing business development activities will lead to substantial growth in Europe in f2002. New contracts, expanded development services and acquisition should drive f2003 revenue to the $500 million range. Patheon is a TOP PICK for 2001. Spar Aerospace (SPZ : TSE : $10.20) Recommendation: STRONG BUY 12-month target price: $11.00 (under review) 52-week price range: $10.25–6.30 Shares O/S: basic 14.6M fully diluted 15.9M Float: 54% Indicated dividend: $0.76 Weekly trading volume: 163,000 Market capitalization: $145.9M Y/E Dec 31 Revenue EBITDA EPS P/E 1998A $123.1M $7.9M $0.38 26.8X 1999A $136.6M $13.1M $0.08 127.5X 2000E $132.0M $19.5M $0.95 10.7X 2001F $145.0M $22.0M $1.25 8.2X Sector: Website: • Technology-Hardware www.spar.ca Spar shares had an impressive total return of 26% in January. The company received regulatory approval to purchase up to 752,000 shares, as well as the authorization to proceed with a $16 million upgrade of airborne collision avoidance and radar altimeter systems on DND’s C130 fleet. Spar also booked a net gain of $0.22/share from the sale of its interest in Vistar Telecommunications to NSI Communications in January. JANUARY 31, 2001 8 SPECIAL SITUATIONS • Supported by a cash-rich balance sheet, management is committed to grow Spar’s aviation services business, internally and through acquisitions. Enterprise Capital Management now has ownership or control and direction over 3.35 million or 23.5% of Spar shares through recent private agreements reached with I.M.P. Group and K.C. Rowe. Spar continues to offer attractive risk/reward and is among our TOP PICKS for 2001. Strongco (SQP : TSE : $1.72) Recommendation: SPECULATIVE BUY 12-month target price: $3.00 52-week price range: $3.85–1.21 Shares O/S: basic 9.4M fully diluted 10.1M Float: 70% Indicated dividend: Nil Weekly trading volume: 66,400 Market capitalization: $16.2M Y/E Dec 31 Revenue CFPS EPS P/E 1998A $607.8M $2.09 $1.00 1.7X 1999A $571.3M $0.58 $(0.15) n/a 2000E $530.0M $1.35 $0.10 17.2X 2001F $550.0M $1.49 $0.30 5.7X Sector: Website: Fabricating & Engineering www.strongco.com • Strongco recently sold its entire equipment distribution operation in the Mid-Atlantic States of Virginia, Pennsylvania and New Jersey, for about $76 million. This divestment will eliminate about $0.07/share of losses, result in a pre-tax gain of roughly $3 million, and improve the total debt-to-equity ratio to 2.2 times from 3.1 times. The $13 million of cash proceeds will be used to improve Canadian operations. • While this transaction is a major step to reduce Strongco’s balance sheet leverage, the debt level remains high. Management needs to strengthen further the company’s financial position and operations to rekindle investor interest. Notice that the current share price represents a 72% discount to the $6.12 tangible book value. Toromont Industries (TIH : TSE : $15.30) Recommendation: BUY 12-month target price: $20.00 52-week price range: $20.75–14.50 Shares O/S: basic 28.9M fully diluted 30.2M Float: 70% Indicated dividend: $0.32 Weekly trading volume: 70,500 Market capitalization: $442.2M Y/E Dec 31 Revenue CFPS EPS 1998A $683.5M $1.43 $0.96 1999A $723.9M $1.61 $1.09 2000A $800.5M $1.79 $1.12 2001E $830.0M $1.96 $1.25 Sector: Website: • P/E 15.9X 14.0X 13.7X 12.2X Fabricating & Engineering www.toromont.com Despite the adverse impact of the Concord strike in mid-year that reduced EPS by about $0.08, Toromont posted record results for f2000. While revenues were up 10.6% to $800.5 million, EPS increased 2.8% to $1.12. High conversions of equipment under the rent-to-own options, strong results from Battlefield Equipment Rentals, and a healthy increase in shipments of gas compression packages by Toromont Process Systems contributed to the record performance. JANUARY 31, 2001 9 SPECIAL SITUATIONS • Although the overall operating environment remains positive at this time, management is “guarded” about the outlook for f2001, citing weakness in the economy, declining credit availability and gyrations in financial markets. However, with a strong balance sheet Toromont will be able to weather a downturn and to pursue expansion opportunities. Toromont is a BUY at the current level for long-term, portfolio investors. Versacold (ICE : TSE : $6.00) Recommendation: MARKET PERFORM 12-month target price: $6.00 52-week price range: $8.00–4.30 Shares O/S: basic 9.7M fully diluted 10.5M Float: 27% Indicated dividend: Nil Weekly trading volume: 2,000 Market capitalization: $58.2M Y/E Dec 31 Sales EBITDA EPS P/E 1998A $117.8M $26.2M $0.42 14.3X 1999A $120.2M $21.5M $0.16 37.5X 2000E $128.0M $23.4M $0.22 27.3X 2001F $125.0M $25.5M $0.30 20.0X Sector: Web site address: Wholesale Distributors www.versacold.com • The thinly traded Versacold shares recovered 26% in January and they are now selling above the $5.50 book value. The company recently appointed Brent Sugden as president and CEO, as well as a director. Mr. Sugden has held senior management positions with Tibbett & Britten Gorup North America, Overwaitea Food Group in Alberta, and Associated Grocers, also in Alberta. • Versacold has experienced considerable growing pains in developing its logistics, distribution and supply chains capability. The experience of Mr. Sugden should help Versacold to better manage its customers’ combined refrigerated and dry goods supply chains requirement. Hopefully, better days are ahead. Wajax (WJX : TSE : $4.15) Recommendation: 12-month target price: 52-week price range: Shares O/S: basic fully diluted Float: Indicated dividend: Weekly trading volume: Market capitalization: Y/E Dec 31 1998A 1999A 2000E 2001F Revenue $992.3M $1,038.4M $1,155.0M $1,250.0M Sector: Website: • BUY $8.00 $5.50–3.25 15.7M 16.3M 52% Nil 300,000 $65.2M CFPS $1.29 $1.81 $1.82 $2.06 EPS $0.60 $0.25 $0.70 $0.85 P/E 6.9X 16.6X 5.9X 4.9X Fabricating & Engineering www.wajax.com While Wajax has achieved significantly improved profitability and debt reduction in f2000, it will take another four years for the repositioning strategy to be fully deployed. The strategy lies in transforming the foundation of the company’s business to an after-market and service orientation that will be supported by a wholesale goods and parts distribution business, delivered through a low-cost logistics network, and managed with a stat-of-the-art information system. A significant downturn in the economy will detour this plan. JANUARY 31, 2001 10 SPECIAL SITUATIONS • Despite the positive progress made by management, Wajax shares continue to sell at a deep discount to the $8.52 tangible book value and at very low P/Es. The thinly traded Wajax shares are a BUY and the down side risk is small. We expect Wajax will soon decide its course of action on subsidiary Pacific North Equipment. JANUARY 31, 2001 11 SPECIAL SITUATIONS Canaccord Capital Corporation may have assumed an underwriting liability and/or entered into an agency agreement with respect to the securities mentioned herein. JANUARY 31, 2001 12 SPECIAL SITUATIONS Canaccord Capital Corporation VANCOUVER – HEAD OFFICE TORONTO MONTRÉAL CALGARY LONDON PARIS P.O. Box 10337 Pacific Centre 2200 – 609 Granville Street Vancouver, BC V7Y 1H2 Phone: (604) 643-7300/ (800) 663-1899 Fax: (604) 643-7606 P.O. Box 6 1200 – 320 Bay Street Toronto, Ontario M5H 4A6 Phone: (416) 869-7368/ (800) 896-1058 Fax: (416) 869-7356 1010, rue Sherbrooke ouest Bureau 1100 Montréal, Québec H3A 2R7 Phone: (514) 844-5443 Fax: (514) 844-5216 Suite 400, 409 – 8th Ave. S.W. Calgary, Alberta T2P 1E3 Phone: (403) 508-3800 Fax: (403) 508-3810 Canaccord Capital (Europe) Limited 1st Floor, Brook House 27 Upper Brook Street London W1Y 1PD Phone: 44-20-75182777 Fax: 44-20-7518-2778/9 Canaccord Capital (Europe) Limited 3rd Floor 42, avenue de la Grande Armée 75017 Paris, France Phone: 33-1 56 68 33 00 Fax: 33-1 56 68 99 58 RESEARCH Director of Research James Muir, CFA, Toronto Research Editor & Administration Beth Claridge, Toronto Capital Markets Strategy Michael Manford, Toronto Portfolio Strategy Nick Majendie, Vancouver (416) 869-3290 (416) 869-3403 (604) 643-7542 44-20-7518-7368 (604) 643-7067 (416) 869-6595 (604) 643-7005 Jinsong Shu, Associate, Vancouver (604) 643-7758 MINING Metals & Minerals Greg Barnes, Toronto Roger Chaplin, London Graeme Currie, Vancouver Gold & Precious Minerals Brian Christie, Toronto Michael Jones, London Brad Humphrey, Associate, Toronto Commodities (Metals) Rhona O’Connell, London (416) 869-3092 44-20-7518-7364 (604) 643-7405 (416) 869-7918 44-20-7518-7365 (416) 869-3650 44-20-7518-7362 ENERGY Oil & Gas Gord Currie, CFA, Calgary Jeffrey Fiell, CFA, Calgary Martin Pelletier, Associate, Calgary Charlie Sharp, London Royalty Trusts & Income Funds Doug Sims, Calgary Oilfield Services & Environmental Sara Elford, CFA, Vancouver NEW ECONOMY Technology Software Paul Bradley, Toronto Robert Silgardo, Associate, Toronto Hardware Jonathan Hykawy, Ph.D., Toronto Electronic Commerce & Internet Jeff Rath, CFA, Toronto Jim Zadra, CA, Vancouver Electronic Commerce & Merchandising Jamie Spreng, Montréal Health Sciences & Biotechnology Wayne Schnarr, Ph.D., Toronto Communications & Media Benoît Dubé, Montréal Simon Simonian, Associate, Montréal Telecommunications Mark Horn, London Nick Strube, CFA, Toronto ABBOTSFORD 200 – 32071 South Fraser Way Abbotsford, BC V2T 1W3 Phone: (604) 504-1504 Fax: (604) 504-0420 RESEARCH (CONT’D) Special Situations Tony Yue, Ph.D., VP, Vancouver Raj Karia, London Royalty Trusts & Income Funds Alan Berge, CFA, Vancouver AMOS 131 First Avenue West Suite 300 Amos, PQ J9T 1V1 Phone: (819) 732-7733 Fax: (819) 732-1700 EDMONTON Suite 2700 Manulife Place 10180 – 101st Street Edmonton, Alberta T5J 3S4 Phone: (780) 408-1500 Fax: (780) 408-1501 KELOWNA Landmark Square II Suite 602 – 1708 Dolphin Ave. Kelowna, BC V1Y 9S4 Phone: (250) 712-1100 Fax: (250) 712-1140 AURORA 128 Treegrove Circle Aurora, Ontario L4G 6L9 KINGSTON The Woolen Mill #208 – 4 Cataraqui Street (403) 508-3805 (403) 508-3860 (403) 508-3804 44-20-7518-7366 (403) 508-3806 (604) 643-7739 (416) 869-7920 (416) 869-3260 PUBLICATIONS Beth Claridge, Editor, Toronto 3403 Corrine Kubota, Daily Letter, Vancouver 7334 Faith Van Wart, Desktop Publisher, Toronto 3515 Irene Wong, Desktop Publisher, Vancouver 7087 (416) 869(604) 643(416) 869(604) 643- PRIVATE CLIENT INVESTMENTS Manager Gord Chan, Vancouver Market Analysts Andrew Muir, CFA, Vancouver Colin Cieszynski, Toronto 4543 US Research Co-ordinator Brent Woyat, Vancouver 7485 (604) 643-7054 (604) 643-7008 (416) 867(604) 643- INSTITUTIONAL EQUITIES Director of Sales & Trading Matthew Gaasenbeek, Toronto Ruth Sternberg, Sales Assistant, Toronto (416) 869-3625 (416) 869-3414 Equities Sales Steve Anderson, Toronto Glen Milne, Toronto Graham Saunders, Toronto Carolyn Tanner, Toronto Paul Bernard, Montréal Mark Shannon, Montréal Rod Matheson, Calgary Vince Tattersall, Vancouver Laura Werth, Sales Assistant, Vancouver (416) 869-3548 (416) 869-3666 (416) 869-3888 (416) 869-3614 (514) 844-3506 (514) 284-3902 (403) 508-3822 (604) 643-7384 (604) 643-7052 Equities Trading Bob Lee, Toronto Jim McMerty, Toronto Jake Poulstrup, Toronto Chris Rigby, Toronto Ron Campbell, Montréal Julie Walsh, Montréal Daren Rahal, Vancouver (416) 869-3761 (416) 869-3178 (416) 869-7924 (416) 869-3326 (514) 844-3547 (514) 844-2982 (604) 643-7061 (416) 869-7922 (416) 869-3325 (604) 643-7031 (514) 844-3790 (416) 869-3028 (514) 844-3630 (514) 844-3621 44-20-7518-7369 (416) 869-3073 BRANCHES NANAIMO 75 Commercial Street Nanaimo, BC V9R 5G3 Phone: (250) 754-1111 Fax: (250) 754-4266 EQUITY CAPITAL MARKETS Ron Sedran, Director of Syndication, Toronto Sandy Kipping, Syndication OTTAWA World Exchange Plaza Suite 830, 45 O’Connor Street Ottawa, Ontario K1P 1A4 Phone: (613) 233-3158/(888) 8999994 Fax: (613) 233-9338 PRINCE GEORGE 1520 – 3rd Ave. Prince George, BC V2L 3G4 (416) 869-3198 (416) 869-3349 SIMCOE 49 Robinson Street Simcoe, Ontario N3Y 1W5 Phone: (519) 428-7525 Fax: (519) 428-1198 VICTORIA Suite 100, 880 Douglas Street Victoria, BC V8W 2B7 Phone: (250) 388-5354 Fax: (250) 978-5300 VANCOUVER – BENTALL Suite 1200 – 595 Burrard Street Vancouver, BC V7X 1J1 Phone: (604) 688-0133 Fax: (604) 682-2574 WATERLOO Suite 101, 80 King Street South Waterloo, Ontario N2J 1P5 Phone: (519) 886-1060 Fax: (519) 886-1686 VERNON 3108 – 30th Ave. Vernon, BC V1T 2C2 WHITEHORSE 206D Jarvis Street Whitehorse, YT Y1A 2H1 The information contained in this report is drawn from sources believed to be reliable, but the accuracy and completeness of the information is not guaranteed, nor n providing it does Canaccord Capital Corporation (“Canaccord Capital”) assume any liability. This information is given as of the date appearing on this report, and Canaccord Capital assumes no obligation to update the information or advise on further developments relating to these securities. This report is intended for distribution in those jurisdictions where Canaccord Capital is registered as an advisor or a dealer in securities. Any distribution or dissemination of this report in any other jurisdiction is strictly prohibited. Canaccord Capital, its affiliated companies and holdings of their respective directors, officers and employees and companies with which they are associated may, from time to time, include the securities mentioned in this report. SPECIAL SITUATIONS Phone: (905) 713-2464 Fax: (905) 713-1250 Kingston, Ontario K7K 1Z7 Phone: (613) 547-3997 Fax: (613) 547-4472 Phone: (250) 562-7255 Fax: (250) 562-1022 Phone: (250) 558-5431 Fax: (250) 558-5439 Phone: (867) 668-7111 Fax: (867) 668-6150 CAMPBELL RIVER 1196 Elm Street Campbell River, BC V9W 3A2 Phone: (250) 287-8807 Fax: (250) 287-8248 The information contained in this report is drawn from sources believed to be reliable, but the accuracy and completeness of the information is not guaranteed, nor n providing it does Canaccord Capital Corporation (“Canaccord Capital”) assume any liability. This information is given as of the date appearing on this report, and Canaccord Capital assumes no obligation to update the information or advise on further developments relating to these securities. This report is intended for distribution in those jurisdictions where Canaccord Capital is registered as an advisor or a dealer in securities. Any distribution or dissemination of this report in any other jurisdiction is strictly prohibited. Canaccord Capital, its affiliated companies and holdings of their respective directors, officers and employees and companies with which they are associated may, from time to time, include the securities mentioned in this report.